📰 Robert Postma News
Robert Postma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Robert Postma. Real-time updates on events, politics, business and more.
November 15, 2023
Grasp the chance to see the northern lights, tour unparalleled scenery, try dog sledding and so much more.
November 15, 2023
Grasp the chance to see the northern lights, tour unparalleled scenery, try dog sledding and so much more
July 16, 2023
From remote national parks to picturesque islands, don't miss these Canadian destinations.
August 31, 2022
Alaunos has undergone a name change and a staff and management overhaul over the past 12 months.
March 29, 2022
In mainland Iceland's northernmost town, the women who powered the herring industry – and fought for gender equality – are driving a new tourism boom.
December 16, 2021
And while you’re there, don’t forget to try dog-sledding, polar-bear-watching and the local dining.
February 5, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Ziopharm Oncology Announces Election of Robert Postma to its Board of Directors ZIOPHARM Oncology IncFebruary 5, 2021 GMT BOSTON, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or “the Company”) (Nasdaq:ZIOP) today announced the election of Robert Postma to its Board of Directors (the “Board”), effective immediately. Mr. Postma is the Founder of WaterMill Asset Manag...
February 5, 2021
Author Bio Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Follow @keithspeights What happened Shares of Ziopharm Oncology (NASDAQ:ZIOP) were soaring 11.8% as of 11:45 a.m. EST on Friday. The nice gain came after the company announced the election of Rober...
December 11, 2020
s Independent financial analysts widely recognize this progress: “ZIOP continues to make progress with respect to the company-sponsored TCR-T program, the Controlled IL-12 program, and the Sleeping Beauty CAR-T program.” 2 “By unlocking the potential of its Sleeping Beauty technology, the Company is poised to deliver a leap forward in the personalization of cancer therapy.” 3 “We think that the company continues to make forward progress across its various platforms (TCR-T, CAR-T, and ...